ABBVON

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.

Kripto AdıABBVON

SıralamaNo.3358

Piyasa Değeri$0.00

Tamamen Seyreltilmiş Değer$0.00

Pazar Payı%

İşlem Hacmi/Piyasa Değeri (24 Sa)912,200.21%

Dolaşımdaki Arz125.85292924

Maksimum Arz0

Toplam Arz125.85292924

Dolaşım Oranı%

Arz Tarihi--

Varlığın ilk arz edildiği fiyat--

Tüm Zamanların En Yükseği237.64005999136555,2026-03-05

En Düşük Fiyat193.3720963640878,2026-04-29

Herkese Açık Blok ZinciriETH

HakkındaAbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.

Sektör

Sosyal Medya

• Resmi Websitesi
• Blok Gezgini

etfindex:mc_etfindex_sourceYasal Uyarı: Veriler cmc tarafından sağlanmıştır ve yatırım tavsiyesi olarak değerlendirilmemelidir.